A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions

Journal:

Journal of Clinical Investigation

Published:

2026-02-05

DOI:

10.1172/jci199277

Affiliations:

12

Authors:

25

Go to article

Institutions	Authors	Share
University of California, San Francisco (UCSF), United States of America (USA)	11.500000 11.500000	0.46
Chan Zuckerberg Biohub (CZ Biohub), United States of America (USA)	6.500000	0.26
American Red Cross, United States of America (USA)	2.000000	0.08
NYU Langone Health, United States of America (USA)	2.000000	0.08
Baylor College of Medicine (BCM), United States of America (USA)	1.000000	0.04
Johns Hopkins University (JHU), United States of America (USA)	1.000000	0.04
Bolivian Catholic University (UCB), Bolivia	1.000000	0.04

Interested in Clinical Sciences?